Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 5, 2007, Pages 638-650

  Schipper, Meike L ^a,c   Riese, Christoph G U ^a   Seitz, Stephan ^a   Weber, Alexander ^a   Béhé, Martin ^a   Schurrat, Tino ^a   Schramm, Nils ^b   Keil, Boris ^a   Alfke, Heiko ^a   Behr, Thomas M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c STANFORD UNIVERSITY   (United States)

Author keywords

99mTc pertechnetate; Neuroendocrine tumors; Radioisotope therapy; Single photon emission computed tomography; Sodium iodide symporter

Indexed keywords

PERTECHNETIC ACID TC 99M; SODIUM IODIDE I 131; SODIUM IODIDE SYMPORTER; COTRANSPORTER; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CLONOGENESIS; COLLIMATOR; CONTROLLED STUDY; DATA ANALYSIS; DRUG UPTAKE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY; REPORTER GENE; SALIVARY GLAND; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; STOMACH; THYROID GLAND; TRANSGENE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; METABOLISM; METHODOLOGY; NUDE MOUSE; RADIOTHERAPY; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROENDOCRINE TUMORS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY; SODIUM PERTECHNETATE TC 99M; SYMPORTERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34247611479     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0254-8     Document Type: Article

References (50)

1. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-60.
2. Heufelder AE, Morgenthaler N, Schipper ML, Joba W. Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies. Thyroid 2001;11:839-47.
3. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003;24:48-77.
4. Chow SM, Law SC, Mendenhall WM, Au SK, Chan PT, Leung TW, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 2002;52:784-95.
5. Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000;60:3484-92.
6. Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both twoand three-dimensional models. Cancer Gene Ther 2000;7:1529-36.
7. Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, et al. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther 2002;9:1139-45.
8. Dadachova E, Bouzahzah B, Zuckier LS, Pestell RG. Rhenium-188 as an alternative to iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Nucl Med Biol 2002;29:13-8.
9. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood 2003;102:489-96.
10. Haberkorn U. Gene therapy with sodium/iodide symporter in hepatocarcinoma. Exp Clin Endocrinol Diabetes 2001;109:60-2.
11. La Perle KM, Blomme EA, Capen CC, Jhiang SM. Effect of exogenous human sodium iodide symporter expression on growth of MATLyLu cells. Thyroid 2003;13:133-40.
12. Mandell RB, Mandell LZ, Link CJ Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999;59:661-8.
13. Min JJ, Chung JK, Jin Lee Y, Hoon Shin J, Seok Yeo J, Min Jeong J, et al. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol 2002;29:537-45.
14. Nakamoto Y, Saga T, Misaki T, Kobayashi H, Sato N, Ishimori T, et al. Establishment and characterization of a breast cancer cell line expressing Na+/I? symporters for radioiodide concentrator gene therapy. J Nucl Med 2000;41:1898-904.
15. Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Potter E. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging 2002;29:842-54.
16. Sieger S, Jiang S, Schonsiegel F, Eskerski H, Kubler W, Altmann A, et al. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3). Eur J Nucl Med Mol Imaging 2003;30:748-56.
17. Smit JW, Schroder-van der Elst JP, Karperien M, Que I, Stokkel M, van der Heide D, et al. Iodide kinetics and experimental 131I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line. J Clin Endocrinol Metab 2002;87:1247-53.
18. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 2001;8:1524-31.
19. Schipper ML, Weber A, Behe M, Goke R, Joba W, Schmidt H, et al. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells. Cancer Res 2003;63:1333-8.
20. Barton KN, Tyson D, Stricker H, Lew YS, Heisey G, Koul S, et al. GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Mol Ther 2003;8:508-18. 21. Cho JY. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy. Curr Gene Ther 2002;2:393-402.
21. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004;103:1641-6.
22. Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002;13:1723-35.
23. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80.
24. Behr M, Schmitt TL, Espinoza CR, Loos U. Cloning of a functional promoter of the human sodium/iodide-symporter gene. Biochem J 1998;331 (Pt 2):359-63.
25. 131I-iodide to glioma tumor cells expressing the sodium/iodide symporter. J Nucl Med 2003;44:1827-38.
26. 211At]astatide in NIS-transfected human cancer cells. Nucl Med Biol 2002;29:729-39.
27. 99mTc: evaluation of dose and chromosome aberrations in irradiated lymphocytes. Cell Mol Biol (Noisy-le-grand) 2001;47:545-8.
28. Griffiths GL, Govindan SV, Sgouros G, Ong GL, Goldenberg DM, Mattes MJ. Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies. Int J Cancer 1999;81:985-92.
29. 99mTc radiopharmaceuticals. Med Phys 1994;21:1921-6.
30. Nettleton JS, Lawson RS. Cellular dosimetry of diagnostic radionuclides for spherical and ellipsoidal geometry. Phys Med Biol 1996;41:1845-54.
31. Schurrat T, Alfke H, Behe M, Maina T, Nock B, Macke H, et al. Molecular gastrin receptor localisation in mice using high-resolution SPET-MRI image fusion. Eur J Nucl Med Mol Imaging 2003;30:800.
32. Schramm N, Ebel G, Engeland U, Schurrat T, Behe M, Behr TM. High-resolution SPECT using multipinhole collimation. IEEE Trans Nucl Sci 2003;50:315-20.
33. Schurrat T. Ein hochauflösender hochsensitiver Multipinhole- Einzelphotonen-Emissionscomputertomograph für Kleintier-Bildgebung. Department of Nuclear Medicine/Physics, Philipps University Marburg, Germany; 2004.
34. Alfke H, Stoppler H, Nocken F, Heverhagen JT, Kleb B, Czubayko F, et al. In vitro MR imaging of regulated gene expression. Radiology 2003;228:488-92.
35. Heverhagen JT, Hahn HK, Wegmann M, Herz U, Whitaker CD, Matschl V, et al. Volumetric analysis of mice lungs in a clinical magnetic resonance imaging scanner. MAGMA 2004;17:80-5.
36. Wells WM 3rd, Viola P, Atsumi H, Nakajima S, Kikinis R. Multimodal volume registration by maximization of mutual information. Med Image Anal 1996;1:35-51.
37. Boland A, Magnon C, Filetti S, Bidart JM, Schlumberger M, Yeh P, et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Thyroid 2002;12:19-26.
38. Huang M, Batra RK, Kogai T, Lin YQ, Hershman JM, Lichtenstein A, et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 2001;8:612-8.
39. Zhang L, Sharma S, Zhu LX, Kogai T, Hershman JM, Brent GA, et al. Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells. Cancer Res 2003;63:5065-72.
40. Haberkorn U, Beuter P, Kubler W, Eskerski H, Eisenhut M, Kinscherf R, et al. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells. J Nucl Med 2004;45:827-33.
41. Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, et al. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001;42:317-25.
42. 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I? symporter gene. Endocrinology 1997;138:4493-6.
43. Dingli D, Bergert ER, Bajzer Z, O'Connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun 2004;325:157-66.
44. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000;6:871-8.
45. Munzenrider JE. Recent advances in radiotherapy. Rev Interam Radiol 1977;2:123-33.
46. Iyer M, Salazar FB, Lewis X, Zhang L, Wu L, Carey M, et al. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res 2005;14:47-55.
47. Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L, et al. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 2004;10:545-52.
48. Sato M, Johnson M, Zhang L, Gambhir SS, Carey M, Wu L, et al. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer. Clin Cancer Res 2005;11:3743-9.
49. Furuya F, Shimura H, Miyazaki A, Taki K, Ohta K, Haraguchi K, et al. Adenovirus-mediated transfer of thyroid transcription factor-1 induces radioiodide organification and retention in thyroid cancer cells. Endocrinology 2004;145:5397-405.
50. Wenzel A, Upadhyay G, Schmitt TL, Loos U. Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS. Mol Cell Endocrinol 2003;213:99-108.